Mikael Hoffmann
Impact in
-
- Antibiotic Use and Resistance
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Menopause: Health Impacts and Treatments 11
-
- Patient-Provider Communication in Healthcare 3
- Co-authors
- Björn Wettermark (3 shared papers)Susanna M. Wallerstedt (6 shared papers)Lotta Lindh‐Åstrand (11 shared papers)Mats Hammar (11 shared papers)Karin Kjellgren (10 shared papers)Karolina Andersson Sundell (2 shared papers)Lars L. Gustafsson (4 shared papers)Brian Godman (1 shared paper)
- Journals
- Maturitas (5 papers)European Journal of Clinical Pharmacology (3 papers)Basic & Clinical Pharmacology & Toxicology (3 papers)Climacteric (3 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Mikael Hoffmann
46 papers receiving 975 citations
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 34
- Geriatrics and Gerontology 58
- Family Practice 28
- Endocrinology, Diabetes and Metabolism 173
- Toxicology 29
Countries citing papers authored by Mikael Hoffmann
This map shows the geographic impact of Mikael Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Hoffmann more than expected).
Fields of papers citing papers by Mikael Hoffmann
This network shows the impact of papers produced by Mikael Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Hoffmann. The network helps show where Mikael Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Mikael Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 195 | |
| 2 | 2013 | 162 | |
| 3 | 2009 | 126 | |
| 4 | 2005 | 68 | |
| 5 | 2016 | 49 | |
| 6 | 2007 | 43 | |
| 7 | 1997 | 34 | |
| 8 | 2011 | 29 | |
| 9 | 2012 | 26 | |
| 10 | 2004 | 23 | |
| 11 | 2006 | 22 | |
| 12 | 2015 | 20 | |
| 13 | 2014 | 20 | |
| 14 | 2013 | 18 | |
| 15 | 2003 | 16 | |
| 16 | 2022 | 14 | |
| 17 | 2018 | 14 | |
| 18 | [Opioid prescription changes in Sweden 2000–2015]. | 2017 | 13 |
| 19 | 2019 | 12 | |
| 20 | 2014 | 11 |
About Mikael Hoffmann
Mikael Hoffmann is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions, Geriatrics and Gerontology, Family Practice and Economics and Econometrics, having authored 49 papers that have together received 1.0k indexed citations. Recurring topics across this work include Menopause: Health Impacts and Treatments (11 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Medication Adherence and Compliance (5 papers), Blood Pressure and Hypertension Studies (4 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Patient-Provider Communication in Healthcare (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (34 citations), Geriatrics and Gerontology (58 citations), Family Practice (28 citations), Endocrinology, Diabetes and Metabolism (173 citations) and Toxicology (29 citations). Mikael Hoffmann has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Björn Wettermark, Susanna M. Wallerstedt, Lotta Lindh‐Åstrand, Mats Hammar, Karin Kjellgren, Karolina Andersson Sundell, Lars L. Gustafsson, Brian Godman, Jan Brynhildsen and Alan Haycox. Their work appears in journals such as Maturitas, European Journal of Clinical Pharmacology, Basic & Clinical Pharmacology & Toxicology, Climacteric and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.